BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31119466)

  • 1. Effect of Inositol Hexaphosphate (IP
    Ikenaga T; Kakumoto K; Kohda N; Yamamoto T
    Plant Foods Hum Nutr; 2019 Sep; 74(3):316-321. PubMed ID: 31119466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phytic acid on postprandial serum uric acid level in healthy volunteers: a randomized, double-blind, crossover study.
    Ikenaga T; Noguchi H; Kakumoto K; Kohda N; Tsukikawa H; Matsuguma K; Yamamoto T
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(4):504-517. PubMed ID: 31469027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Uric Acid-Lowering Effects of Combined Glycine and Tryptophan Treatments in Subjects with Mild Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Oshima S; Shiiya S; Nakamura Y
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30845731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia.
    Pingali U; Nutalapati C; Koilagundla N; Taduri G
    BMC Complement Med Ther; 2020 Sep; 20(1):281. PubMed ID: 32933504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial.
    Shi Y; Williamson G
    Br J Nutr; 2016 Mar; 115(5):800-6. PubMed ID: 26785820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for hyperuricemia in hypertensive patients.
    Gois PH; Souza ER
    Cochrane Database Syst Rev; 2013 Jan; (1):CD008652. PubMed ID: 23440832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
    Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of
    Lee S; Han EH; Lee SH; Lim MK; Kim CO; Kang S
    J Med Food; 2020 May; 23(5):508-514. PubMed ID: 32150484
    [No Abstract]   [Full Text] [Related]  

  • 10. Acupuncture for serum uric acid in patients with asymptomatic hyperuricemia: A randomized, double-blind, placebo-controlled trial.
    Huang Y; Meng J; Sun B; Xiang T; Zhou X; Xu B; Wu Y; Chen Z; Zhang S
    Int J Cardiol; 2017 Apr; 232():227-232. PubMed ID: 28087178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial for Evaluation of the Efficacy and Safety of DKB114 on Reduction of Uric Acid in Serum.
    Park YH; Kim DH; Lee JS; Jeong HI; Lee KW; Kang TH
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33322063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S35-43. PubMed ID: 21654268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia.
    Takir M; Kostek O; Ozkok A; Elcioglu OC; Bakan A; Erek A; Mutlu HH; Telci O; Semerci A; Odabas AR; Afsar B; Smits G; ALanaspa M; Sharma S; Johnson RJ; Kanbay M
    J Investig Med; 2015 Dec; 63(8):924-9. PubMed ID: 26571421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a Novel Fixed Combination of Nutraceuticals on Serum Uric Acid Concentrations and the Lipid Profile in Asymptomatic Hyperuricemic Patients : Results from the PICONZ-UA Study.
    Rozza F; Trimarco V; Izzo R; Grassi D; Ferri C
    High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):381-386. PubMed ID: 27644242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.
    Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Palo WA; Eustace D; Vernillet L; Joseph-Ridge N
    Arthritis Rheum; 2005 Mar; 52(3):916-23. PubMed ID: 15751090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double-blind, placebo-controlled study.
    Hosoya T; Sasaki T; Hashimoto H; Sakamoto R; Ohashi T
    J Clin Pharm Ther; 2016 Jun; 41(3):298-305. PubMed ID: 27079434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pallidifloside D, a saponin glycoside constituent from Smilax riparia, resist to hyperuricemia based on URAT1 and GLUT9 in hyperuricemic mice.
    Wu XH; Ruan JL; Zhang J; Wang SQ; Zhang YW
    J Ethnopharmacol; 2014 Nov; 157():201-5. PubMed ID: 25267580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Supplementation with Glycine and Tryptophan Reduces Purine-Induced Serum Uric Acid Elevation by Accelerating Urinary Uric Acid Excretion: A Randomized, Single-Blind, Placebo-Controlled, Crossover Study.
    Oshima S; Shiiya S; Nakamura Y
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31652875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisone in Uric Acid lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) study.
    Liu C; Zhao Q; Zhen Y; Gao Y; Tian L; Wang L; Ji L; Liu G; Ji Z; Liu K
    Can J Cardiol; 2013 Sep; 29(9):1048-54. PubMed ID: 23395281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of total saponin of dioscorea on uric acid excretion indicators in chronic hyperuricemia rats].
    Chen GL; Wu S; Na S; Li L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jan; 34(1):75-80. PubMed ID: 24520793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.